Clinicopathologic factors affecting recurrence after curative surgery for stage I colorectal cancer

Journal of the Korean Society of Coloproctology

Volumn 28, Issue 1, 2012, Pages 49-55

  Keum, Min Ae ^a   Lim, Seok Byung ^a   Kim, Sun A ^a   Yoon, Yong Sik ^a   Kim, Chan Wook ^a   Yu, Chang Sik ^a   Kim, Jin Cheon ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Colorectal neoplasms; Recurrence; Risk factors

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER INVASION; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CELL BUDDING; CHEMORADIOTHERAPY; COLORECTAL CARCINOMA; DISEASE DURATION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROPORTIONAL HAZARDS MODEL; RECTUM CANCER; RECURRENCE RISK; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT DURATION;

EID: 84863611093     PISSN: 20937822     EISSN: 20937830     Source Type: Journal    
DOI: 10.3393/jksc.2012.28.1.49     Document Type: Article

References (28)

1. Cancer.go.kr [Internet]. Goyang: National Cancer Information Cencer, Korea Central Cancer Registry; 2008 [cited 2011 Aug I]. Cancer incidence in Korea 1999-2002. Available from: http://www.cancer.go.kr/cms/data/edudata/- icsFiles/afieldfile/2009/09/16/aa(aa0606).pdf.
2. Park DD, Shin R, Kim JS, Oh HK, Jeong SY, Park KJ, et al. Clinical features of colorectal cancer detected by the national cancer screening program. J Korean Soc Coloproctol 2010;26:420-3.
3. Edge SB; American Joint Committee on Cancer. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.
4. Cohen AM, Kelsen D, Saltz L, Minsky BD, Nelson H, Farouk R, et al. Adjuvant therapy for colorectal cancer. Curr Probl Surg 1997;34:601-76.
5. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Goodman PJ, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990;322:352-8. (Pubitemid 20042739)
6. Stipa S, Nicolanti V, Botti C, Cosimelli M, Mannella E, Stipa F, et al. Local recurrence after curative resection for colorectal cancer: frequency, risk factors and treatment. J Surg Oncol Suppl 1991;2:155-60.
7. Blumberg D, Paty PB, Picon AI, Guillem JG, Klimstra DS, Minsky BD, et al. Stage I rectal cancer: identification of high-risk patients. J Am Coll Surg 1998;186:574-9.
8. Willett CG, Lewandrowski K, Donnelly S, Shellito PC, Convery K, Eliseo R, et al. Are there patients with stage I rectal carcinoma at risk for failure after abdominoperineal resection? Cancer 1992;69:1651-5.
9. Sticca RP, Rodriguez-Bigas M, Penetrante RB, Petrelli NJ. Curative resection for stage I rectal cancer: natural history, prognostic factors, and recurrence patterns. Cancer Invest 1996;14:491-7. (Pubitemid 26338214)
10. Wichmann MW, Müller C, Hornung HM, Lau-Werner U, Schildberg FW; Colorectal Cancer Study Group. Results of long-term follow-up after curative resection of Dukes A colorectal cancer. World J Surg 2002;26:732-6. (Pubitemid 36920351)
11. Steinberg SM, Barwick KW, Stablein DM. Importance of tumor pathology and morphology in patients with surgically resected colon cancer. Findings from the Gastrointestinal Tumor Study Group. Cancer 1986;58:1340-5. (Pubitemid 16053150)
12. Manfredi S, Bouvier AM, Lepage C, Hatem C, Dancourt V, Faivre J. Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population. Br J Surg 2006;93:1115-22. (Pubitemid 44343509)
13. Michelassi F, Vannucci L, Montag A, Goldberg R, Chappell R, Dytch H, et al. Importance of tumor morphology for the long term prognosis of rectal adenocarcinoma. Am Surg 1988;54:376-9.
14. Choi PW, Yu CS, Jang SJ, Jung SH, Kim HC, Kim JC. Risk factors for lymph node metastasis in submucosal invasive colorectal cancer. World J Surg 2008;32:2089-94.
15. Hori H, Fujimori T, Fujii S, Ichikawa K, Ohkura Y, Tomita S, et al. Evaluation of tumor cell dissociation as a predictive marker of lymph node metastasis in submucosal invasive colorectal carcinoma. Dis Colon Rectum 2005;48:938-45. (Pubitemid 40884182)
16. Okuyama T, Oya M, Ishikawa H. Budding as a risk factor for lymph node metastasis in pT1 or pT2 well-differentiated colorectal adenocarcinoma. Dis Colon Rectum 2002;45:628-34. (Pubitemid 34507238)
17. Hase K, Shatney C, Johnson D, Trollope M, Vierra M. Prognostic value of tumor "budding" in patients with colorectal cancer. Dis Colon Rectum 1993;36:627-35. (Pubitemid 23206317)
18. Ueno H, Murphy J, Jass JR, Mochizuki H, Talbot IC. Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology 2002;40:127-32. (Pubitemid 34122114)
19. Müller JM, Tübergen D, Zieren U. After-care in colorectal cancer-data and patient oriented evaluation. Zentralbl Chir 1994;119:65-74. (Pubitemid 24084896)
20. Newland RC, Dent OF, Lyttle MN, Chapuis PH, Bokey EL. Pathologic determinants of survival associated with colorectal cancer with lymph node metastases. A multivariate analysis of 579 patients. Cancer 1994;73:2076-82. (Pubitemid 24107961)
21. Chapuis PH, Dent OF, Fisher R, Newland RC, Pheils MT, Smyth E, et al. A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer. Br J Surg 1985;72:698-702. (Pubitemid 16215165)
22. Minsky BD, Mies C, Rich TA, Recht A, Chaffey JT. Potentially curative surgery of colon cancer: the influence of blood vessel invasion. J Clin Oncol 1988;6:119-27. (Pubitemid 18039999)
23. Horn A, Dahl O, Morild I. The role of venous and neural invasion on survival in rectal adenocarcinoma. Dis Colon Rectum 1990;33:598-601. (Pubitemid 20211452)
24. Lim SB, Yu CS, Jang SJ, Kim TW, Kim JH, Kim JC. Prognostic significance of lymphovascular invasion in sporadic colorectal cancer. Dis Colon Rectum 2010;53:377-84.
25. Park IJ, Kim HC, Yu CS, Kim JC. Pattern of recurrences and metastases after a curative resection for primary colorectal cancer. J Korean Soc Coloproctol 2008;24:207-13.
26. Griesenberg D, Nürnberg R, Bahlo M, Klapdor R. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer. Anticancer Res 1999;19(4A):2443-50. (Pubitemid 29392391)
27. Steele G Jr. Follow-up plans after treatment of primary colon and rectum cancer. World J Surg 1991;15:583-8.
28. Aghili M, Izadi S, Madani H, Mortazavi H. Clinical and pathological evaluation of patients with early and late recurrence of colorectal cancer. Asia Pac J Clin Oncol 2010;6:35-41.